Tapering and discontinuation of methotrexate in patients with RA treated with TNF inhibitors: data from the DREAM registry

OBJECTIVES: To study the number of patients that taper or discontinue concomitant methotrexate (MTX) in daily practice in patients with rheumatoid arthritis (RA) treated with tumour necrosis factor inhibitor (TNFi) and to analyse the effects of that adaption on disease activity and drug survival. ME...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:RMD Open
Prif Awduron: Manders, Sofie H M, van de Laar, Mart A F J, Rongen-van Dartel, Sanne A A, Bos, Reinhard, Visser, Henk, Brus, Herman L, Jansen, Tim, Vonkeman, Harald E, van Riel, Piet L C M, Kievit, Wietske
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Publishing Group 2015
Pynciau:
Rheumatoid Arthritis
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623370/
https://ncbi.nlm.nih.gov/pubmed/26535151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2015-000147
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg